[{"info":{"order":6,"caption":"PROGNOSTIC FINDINGS","type":"table"},"data":[{"Gene":"NRAS","Alteration":"Q61R","Clinical_Significance":"Resistance or Non-Response (B,B,D)","Drug":"Vemurafenib,Cetuximab,Cetuximab","Clone":"1","Notes":"1,2,3"},{"Gene":"NRAS","Alteration":"Q61R","Clinical_Significance":"Poor Outcome (B,B)","Drug":"-","Clone":"1","Notes":"4,5"},{"Gene":"TP53","Alteration":"R249S","Clinical_Significance":"Resistance or Non-Response (D)","Drug":"Docetaxel","Clone":"1","Notes":"6"},{"Gene":"TP53","Alteration":"R249S","Clinical_Significance":"Poor Outcome (B,B,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #FF0000\">B<\/span>,B,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>,B,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">A<\/span>)","Drug":"-","Clone":"1","Notes":"7,8,<span style=\"color: #0000FF\">9<\/span>,<span style=\"color: #0000FF\">10<\/span>,<span style=\"color: #FF0000\">11<\/span>,12,<span style=\"color: #0000FF\">13<\/span>,<span style=\"color: #0000FF\">14<\/span>,15,<span style=\"color: #0000FF\">16<\/span>,<span style=\"color: #0000FF\">17<\/span>,<span style=\"color: #0000FF\">18<\/span>,<span style=\"color: #0000FF\">19<\/span>,<span style=\"color: #0000FF\">20<\/span>,<span style=\"color: #0000FF\">21<\/span>"},{"Gene":"RSF1","Alteration":"GAIN","Clinical_Significance":"Resistance or Non-Response (B)","Drug":"Tamoxifen","Clone":"1","Notes":"22"},{"Gene":"CCNE1","Alteration":"GAIN","Clinical_Significance":"Resistance or Non-Response (D)","Drug":"Palbociclib (PD0332991)","Clone":"1","Notes":"23"},{"Gene":"STK11","Alteration":"DELETION/LOSS","Clinical_Significance":"Resistance or Non-Response (D)","Drug":"Docetaxel,Selumetinib (AZD6244)","Clone":"1","Notes":"24"},{"Gene":"SMAD4","Alteration":"DELETION/LOSS","Clinical_Significance":"Resistance or Non-Response (B)","Drug":"5-fluorouracil","Clone":"3","Notes":"25"},{"Gene":"CCNE1","Alteration":"GAIN","Clinical_Significance":"Poor Outcome (B)","Drug":"-","Clone":"1","Notes":"26"},{"Gene":"CCND1","Alteration":"GAIN","Clinical_Significance":"Poor Outcome (B)","Drug":"-","Clone":"1","Notes":"27"},{"Gene":"PIK3CA","Alteration":"GAIN","Clinical_Significance":"Poor Outcome (B)","Drug":"-","Clone":"1","Notes":"28"},{"Gene":"SMAD4","Alteration":"DELETION/LOSS","Clinical_Significance":"Poor Outcome (B)","Drug":"-","Clone":"3","Notes":"29"},{"Gene":"NOTCH1","Alteration":"GAIN","Clinical_Significance":"Poor Outcome (B)","Drug":"-","Clone":"NA","Notes":"30"},{"Gene":"TERT","Alteration":"GAIN","Clinical_Significance":"Poor Outcome (B)","Drug":"-","Clone":"1","Notes":"31"},{"Gene":"LRP1B","Alteration":"DELETION/LOSS","Clinical_Significance":"Poor Outcome (B)","Drug":"-","Clone":"3","Notes":"32"},{"Gene":"IKZF1","Alteration":"DELETION/LOSS","Clinical_Significance":"Poor Outcome (<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>,<span style=\"color: #0000FF\">B<\/span>)","Drug":"-","Clone":"3","Notes":"<span style=\"color: #0000FF\">33<\/span>,<span style=\"color: #0000FF\">34<\/span>,<span style=\"color: #0000FF\">35<\/span>,<span style=\"color: #0000FF\">36<\/span>,<span style=\"color: #0000FF\">37<\/span>"},{"Gene":"RRM1","Alteration":"OVEREXPRESSION/UPREGULATION","Clinical_Significance":"Resistance or Non-Response (D)","Drug":"Gemcitabine","Clone":"-","Notes":"38"},{"Gene":"PTTG1","Alteration":"OVEREXPRESSION/UPREGULATION","Clinical_Significance":"Poor Outcome (B)","Drug":"-","Clone":"-","Notes":"39"},{"Gene":"ETV4","Alteration":"OVEREXPRESSION/UPREGULATION","Clinical_Significance":"Poor Outcome (B)","Drug":"-","Clone":"-","Notes":"40"}]}]
